Saturday, October 10, 2009

Nanoparticles destroy brain cancer

http://hplusmagazine.com/articles/nano/targeting-cancer-cells-nanoparticles

"Scientists from the University of Chicago and the US Department of Energy have developed the first nanoparticles that seek out and destroy GMB brain cancer cells. Nanoparticles killed up to 80% of the brain cancer cells after just five minutes of exposure to white light, showing the promise of nanomedicine — highly-specific intervention at the molecular scale. Because nanomedicine could repair brain cells or damaged nerve and muscle tissue, the NIH has established eight Nanomedicine Development Centers around the country for their Nanomedicine Roadmap Initiative. Researchers have also used gold nanospheres to search out and 'cook' skin cancer cells with light — 'It's basically like putting a cancer cell in hot water and boiling it to death,' says one researcher. And the NIH Roadmap ultimately predicts 'novel tiny sensors ... that search for, and destroy, infectious agents.'"

Friday, October 9, 2009

Nobel Prize to Obama: Some Considerations

I strongly suspect that Nobel Prize was issued to Obama at this time because the U.S. is rumored to be preparing to bomb Iran, with Iran following closely with a promise of ultimate destruction of Israel if they are attacked. One real quirk is the money that is attached to the prize, 1.4 million dollars. Seems almost like a bribe, doesn't it?

Perhaps this isn't about Obama - perhaps this is about being on the brink of world war. Certainly, the event calls to question the integrity behind the awarding of the Nobel Prize

The 'liberals' are overjoyed and the 'conservatives' are outraged, and the polarization of our culture really shows how easily distracted we have become from matters at hand.

U.S. prepares to bomb Iran:
http://abcnews.go.com/Politics/us-preparing-bomb-iran/story?id=8765343

Iran threatens Israel:
http://www.breitbart.com/article.php?id=D9B7GH200&show_article=1

The nobel prize is often a method for encouraging action rather than recognizing accomplishment (as with the award for scientific or literary accomplishment), and the nominees have been controversial, having included Hitler, Stalin, Mussolini, and Yasser Arafat.

Scholars who studied Nobel have said it was Nobel's way to compensate for developing destructive forces (Nobel's inventions included dynamite and ballistite).

http://en.wikipedia.org/wiki/Nobel_Peace_Prize

Photo Sketch program


http://www.telegraph.co.uk/technology/news/6265876/PhotoSketch-picture-software-wins-plaudits.html


Link to the application site (currently down due to high volume traffic.)
http://cg.cs.tsinghua.edu.cn:8080/cmm/?page_id=155



PhotoSketch, which transforms basic stick-figure drawings in to a photograph, has been described by technology website Mashable as "mind blowing".

The program, which has been built by five Chinese students at Tsinghua University and the National University of Singapore, uses a vast library of images to turn a basic sketch in to a photograph. A website that allows people to experiment with the software has crashed under the volume of traffic.

In one example of the technology, a basic sketch, showing the rudimentary outlines of some boats, seagulls and a kissing bride and groom, is transformed in to a beautiful image showing an embracing couple against a sunset backdrop. In another, a diagram of a man throwing a Frisbee, and a dog leaping to catch it, is turned into an action-packed picture.

The authors of the tool – Tao Chen, Ming-Ming Cheng, Ping Tan, Ariel Shamir, and Shi-Min Hu – say that the software can take any rough sketch showing the shape of each object, labelled with a name, and find images that correspondent to each element. It can also judge between images to decide which is the best match for the picture, and then stitch all of the elements together in a single image, adding shadows to give a naturalistic look and feel.

"Although online image search generates many inappropriate results, our system is able to automatically select suitable photographs to generate a high quality composition, using a filtering scheme to exclude undesirable images," say the PhotoSketch team in an abstract outlining the tool. "We also provide a novel image blending algorithm to allow seamless image composition. Each blending result is given a numeric score, allowing us to find an optimal combination of discovered images. Experimental results show the method is very successful."

Web users have been quick to point out that the tool is initially most likely to be used to create funny images, perhaps showing celebrities in amusing or compromising positions. But technology experts have been quick to recognise the potential of the software.

"It’s early, experimental, and questionably useful, but it’s just too cool," writes Devin Coldewey on CrunchGear. "I don’t want to be premature here, but I’d say tentatively that this does appear to be the greatest thing of all time."

Tuesday, October 6, 2009

Levis commercials from days of yor

Featuring Ken Nordine:



http://www.youtube.com/watch?v=6TRgokZLIwA

Inspired by Star Wars:



http://www.youtube.com/watch?v=BajEfI7g5A0&feature=related

Related, appearance by the same warlord character:




http://www.youtube.com/watch?v=8uSLZGRVTYo&feature=related

Friday, October 2, 2009

Free-flying cyborg insects steered from a distance

http://www.newscientist.com/article/dn17895-freeflying-cyborg-insects-steered-from-a-distance.html

(Video Included)

Article: 01 October 2009 by Ewen Callaway

It's tempting to call them lords of the flies. For the first time, researchers have controlled the movements of free-flying insects from afar, as if they were tiny remote-controlled aircraft.

By connecting electrodes and radio antennas to the nervous systems of beetles, the researchers were able to make them take off, dive and turn on command. The cyborg insects were created at the University of California, Berkeley, by engineers led by Hirotaka Sato and Michel Maharbiz as part of a programme funded by the Pentagon's Defence Advanced Research Projects Agency (DARPA).

The project's goal is to create fully remote-controlled insectsMovie Camera able to perform tasks such as looking for survivors after a disaster, or acting as the ultimate spy.
Green beetles

The Berkeley team implanted electrodes into the brain and muscles of two species: green June beetles called Cotinus texana from the southern US, and the much larger African species Mecynorrhina torquata. Both responded to stimulation in much the same way, but the weight of the electronics and their battery meant that only Mecynorrhina – which can grow to the size of a human palm – was strong enough to fly freely under radio control.

A particular series of electrical pulses to the brain causes the beetle to take off. No further stimulation is needed to maintain the flight. Though the average length of flights during trials was just 45 seconds, one lasted for more than 30 minutes. A single pulse causes a beetle to land again.

The insects' flight can also be directed. Pulses sent to the brain trigger a descent, on average by 60 centimetres. The beetles can be steered by stimulating the wing muscle on the opposite side from the direction they are required to turn, though this works only three-quarters of the time. After each manoeuvre, the beetles quickly right themselves and continue flying parallel to the ground.
Brain insights

Tyson Hedrick, a biomechanist at the University of North Carolina, Chapel Hill, who was not involved in the research, says he is surprised at the level of control achieved, because the controlling impulses were delivered to comparatively large regions of the insect brain.

Precisely stimulating individual neurons or circuits may harness the beetles more precisely, he told New Scientist, but don't expect aerial acrobatics. "It's not entirely clear how much control a beetle has over its own flight," Hedrick says. "If you've ever seen a beetle flying in the wild, they're not the most graceful insects."

The research may be more successful in revealing just how the brain, nerves and muscles of insects coordinate flight and other behaviours than at bringing six-legged cyborg spies into service, Hedrick adds. "It may end up helping biologists more than it will help DARPA."
Brain-recording backpacks

It's a view echoed by Reid Harrison, an electrical engineer at the University of Utah, Salt Lake City, who has designed brain-recording backpacks for insects. "I'm sceptical about their ability to do surveillance for the following reason: no one has solved the power issue."

Batteries, solar cells and piezoelectrics that harvest energy from movement cannot provide enough power to run electrodes and radio transmitters for very long, Harrison says. "Maybe we'll have some advances in those technologies in the near future, but based on what you can get off the shelf now it's not even close."

Journal reference: Frontiers in Integrative Neuroscience, DOI: 10.3389/neuro.07.024.2009

Common Diabetic Drug Fights Cancer Stem Cells

http://online.wsj.com/article/SB10001424052970203278404574413273870984920.html

The drug metformin, a mainstay of diabetes care for 15 years, may have a new life as a cancer treatment, researchers said.

In a study in mice, low doses of the drug, combined with a widely used chemotherapy called doxorubicin, shrank breast-cancer tumors and prevented their recurrence more effectively than chemotherapy alone.

The findings add to a growing body of evidence that metformin, marketed as Glucophage by Bristol-Myers Squibb Co. and available in generic versions, could be a potent antitumor medicine.

They also lend support to an emerging theory that cancer's ability to survive and resist therapy is regulated by cancer stem cells that drive a tumor's growth and survival.

Chemotherapy is effective against many tumors, said Kevin Struhl, a Harvard Medical School researcher and principal investigator of the study. "The problem is cancer stem cells acquire resistance" to treatment, he said. "They are able to regenerate the tumor and as a result you end up with a relapse."

About 5% to 10% of a tumor's cells are believed to be cancer stem cells, he said.

In the report, being published in the Oct. 1 edition of Cancer Research, a journal of the American Association for Cancer Research, researchers said the combination of metformin and doxorubicin killed both regular cancer cells and cancer stem cells.

In contrast, doxorubicin alone had limited effect on the stem cells.

Mice that grew tumors generated from human breast-cancer cells have remained tumor-free for nearly three months on the combined treatment, while tumors have recurred in those not given the diabetes remedy.

Researchers said the results have potentially broad implications for cancer treatment.

"If we could get some magic bullet to hit that stem-cell population, the thought is we could have more effective treatments," said Raymond DuBois, provost and executive vice president, University of Texas M.D. Anderson Cancer Center.

It is too early to tell whether and how metformin might be used to treat cancer patients.

A clinical trial testing metformin alone in early-stage breast-cancer patients, after they have had surgery and chemotherapy to treat their tumors, is being sponsored by the National Cancer Institute of Canada and could begin enrolling patients next year, said Jennifer Ligibel, a breast-cancer doctor at Dana-Farber Cancer Institute, Boston. The idea is to see if metformin is effective in preventing the cancer from recurring. U.S. cancer researchers are participating.

The new findings, she said, suggest that additional trials should evaluate metformin in combination with chemotherapy. She wasn't involved in the current research.

Metformin, which was approved in 1994 to lower blood sugar in people with Type 2 diabetes, achieved peak sales of $2.3 billion in 2001 before patent expirations opened the market to generic competition.

Several recent studies have observed the drug's potential effects against cancer.

One study from M.D. Anderson Cancer Center, for instance, found that diabetic patients treated with metformin were less likely to develop pancreatic cancer than those who weren't taking the drug for blood sugar.

How metformin affects cancer isn't certain, but one possibility is that it deprives tumor cells of sugar.

"Cancer cells are gluttons for glucose," said George Prendergast, president and chief executive officer of Lankenau Institute for Medical Research, Wynnewood, Pa. "It is likely that metformin is taking advantage of this gluttony of the cancer cell in order to attack it."

Another possibility is that the drug affects the immune system and helps stave off a tumor's recurrence, Dr. Struhl said.

The study was sponsored by the National Institutes of Health and the American Cancer Society.

Dr. Struhl and Harvard Medical School have applied for a patent that would cover a combination of metformin and a lower dose of chemotherapy to treat cancer.

Write to Ron Winslow at ron.winslow@wsj.com

Corrections and amplifications:

The diabetes drug metformin is marketed by Bristol-Myers Squibb Co. under the brand name Glucophage. The medication's name was misspelled as Glugophase in a previous version of this article.